First Line Immunotherapy for Advanced Non-Small Cell Lung Cancer: A Great Option for Some, but Not for All

Article

General-Campaign-Logo-300x300Several weeks ago, at a very crowded plenary session for the European Society of Medical Oncology (ESMO) in Copenhagen, Denmark, results with first line immunotherapy compared to standard first line chemotherapy for patients with advanced non-small cell lung cancer (NSCLC) were presented that simultaneously ushered in a new era for testing for PD-L1, the leading predictive marker for sensitivity to immu

Blood Cancers Video Library: CLL and Non Hodgkin Lymphoma: Should all Hodgkin’s Lymphoma patients be treated the same?

Video

GRACE joined a number of top faculty in the area of hematology in Whistler BC, for the 3rd Annual Summit on Hematologic Malignancies. John Kuruvilla, MD, Associate Professor, Princess Margaret Hospital, University Health Network in Toronto, Canada, spoke with GRACE about Chronic Lymphocytic Leukemia (CLL) and Non Hodgkin Lymphoma, and explained that all all Hodgkin’s Lymphoma patients are not treated the same. Much is based on the risk profile in terms of the amount of disease, which will often dictate the treatment approach.

TRANSCRIPT 

 

Blood Cancers Video Library: Are Vaccines Dead in Lymphoma and CLL?

Video

GRACE joined a number of top faculty in the area of hematology in Whistler BC, for the 3rd Annual Summit on Hematologic Malignancies.  Joshua Brody, MD, Oncologist and Director, Assistant Professor of Medicine, Hematology & Medical Oncology at Mount Sinai Hospital spoke with GRACE about the question of whether vaccines are dead in Lymphoma and CLL. 

Are Vaccines Dead in Lymphoma and CLL?

Blood Cancers Video Library: FCR vs BR – Is One Better?

Video

GRACE joined a number of top faculty in the area of hematology in Whistler BC, for the 3rd Annual Summit on Hematologic Malignancies. Jennifer Brown, MD, PhD, Director of the CLL Center at the Dana-Farber Cancer Institute spoke with GRACE and provided a provoking and educational discussion on FCR vs. BR – is one better than the other?

TRANSCRIPT

 

FCR v BR? Is one better?

Jennifer Brown, MD, PhD, Director of the CLL Center at the Dana-Farber Cancer Institute

Lung Cancer Video Library - Basics of Small Cell Lung Cancer

Video
 
Dr. Rachel Sanborn, Providence Thoracic Oncology Program, discusses the topic of lung cancer and that there is an entire spectrum of different kinds of cancers that have started inside the lungs.  Small cell lung cancers behave very differently than non-small cell lung cancer.  

 

 

Basics of Small Cell Lung Cancer

Rachel Sanborn, MD, Medical Oncologist and Co-Director

ASCO 2016 - New Trials of Targeted Therapies to Treat Leptomeningeal Carcinomatosis

Video

GRACE is happy to present the 9th and final video in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer.  Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discussion, moderated by Dr. West, highlights the newest and most intriguing discussions from ASCO 2016.

Drs. West, Vokes and Ramalingam, along with patient advocate Janet Freeman-Daily, discuss new trials of targeted therapies to treat leptomeningeal carcinomatosis.

 

ASCO 2016 - Immuno-oncology Developments - Combinations and Use as First-Line Therapy

Video

GRACE is happy to present the 7th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer.  Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discussion, moderated by Dr. West, highlights the newest and most intriguing discussions from ASCO 2016.

Drs. West, Vokes and Ramalingam, along with patient advocate Janet Freeman-Daily, discuss Immuno-oncology developments: combinations and use as first line therapy.

 

ASCO 2016 - J-ALEX Trial: Should Alecensa Replace Xalkori as first-Line ALK Therapy

Video

GRACE is happy to present the 5th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer.  Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discussion, moderated by Dr. West, highlights the newest and most intriguing discussions from ASCO 2016.

Drs. West, Vokes and Ramalingam, along with patient advocate Janet Freeman-Daily, discuss the J-ALEX trial and whether Alecensa should replace Xalkori as a first-line ALK therapy.

 

 

ASCO 2016 - Can Online Patient Groups Speed The Development Of New Targeted Therapies?

Video

GRACE is happy to present the 2nd in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer.  Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discussion, moderated by Dr. West, highlights the newest and most intriguing discussions from ASCO 2016.

Subscribe to English